MedTrace Logo

Vitamin D in Systemic Sclerosis Patients With Periodontitis

NCT04066842 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 168

Last updated 2019-08-26

No results posted yet for this study

Summary

Vitamin D has been considered to possess anti-inflammatory and antimicrobial activity which may be a link for the known interaction of Systemic Sclerosis (SSc) and coronary heart disease (CHD). This study investigated the association between serum vitamin D levels and SSc and periodontitis in patients with SSc, CP and with CHD.

Furthermore, the objective was to determine if periodontitis and CHD had an impact on serum vitamin D levels.

Conditions

  • Vitamin D Deficiency

Interventions

OTHER

Observation

Evaluation of Vitamin D levels and correlation of Vitamin D levels level with periodontal and cardiovascular disease

Sponsors & Collaborators

  • University of Messina

    lead OTHER

Principal Investigators

  • Gaetano Isola · University of Catania

Eligibility

Min Age
20 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-11-01
Primary Completion
2019-05-15
Completion
2019-05-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04066842 on ClinicalTrials.gov